Cargando…
Serum ADMA concentration – an independent factor determining FMD impairment in cardiac syndrome X
Mechanisms of decreased endogenous vascular reactivity in individuals with cardiac syndrome X (CSX) are not fully understood. AIM: To evaluate the following serum markers: total nitric oxide (NO), asymmetric dimethylarginine (ADMA), platelet-derived growth factor (PDGF), and to establish their relat...
Autores principales: | Haberka, Maciej, Mizia-Stec, Katarzyna, Gąsior, Zbigniew, Mizia, Magdalena, Janowska, Joanna, Holecki, Michał, Zahorska-Markiewicz, Barbara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852773/ https://www.ncbi.nlm.nih.gov/pubmed/19961267 http://dx.doi.org/10.3109/03009730903225537 |
Ejemplares similares
-
N-3 Polyunsaturated fatty acid therapy improves endothelial function and affects adiponectin and resistin balance in the first month after myocardial infarction
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2011) -
Cardiac Amyloidosis-Challenging Diagnosis and Unclear Clinical Picture
por: Kozak, Sylwia, et al.
Publicado: (2021) -
Functional Mitral Regurgitation in Patients with Preserved Ejection Fraction Qualified for Pulmonary Vein Isolation: A Negative Prognostic Factor for Catheter Ablation Efficacy
por: Cichoń, Małgorzata, et al.
Publicado: (2021) -
Angiopoietin-2 as a biomarker of non-ST-segment elevation myocardial infarction in patients with or without type 2 diabetes
por: Skowerski, Tomasz, et al.
Publicado: (2019) -
FOXO1 and ANGPT2 relative gene expression in non-ST-segment elevation myocardial infarction among patients with or without type 2 diabetes
por: Skowerski, Tomasz, et al.
Publicado: (2021)